Solara Active Pharma Sciences Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
Solara Active Pharma Sciences's earnings have been declining at an average annual rate of -72.5%, while the Pharmaceuticals industry saw earnings growing at 13.4% annually. Revenues have been declining at an average rate of 1.7% per year.
Anahtar bilgiler
-72.5%
Kazanç büyüme oranı
-71.9%
EPS büyüme oranı
| Pharmaceuticals Sektör Büyümesi | 17.5% |
| Gelir büyüme oranı | -1.7% |
| Özkaynak getirisi | -49.3% |
| Net Marj | -43.9% |
| Son Kazanç Güncellemesi | 30 Sep 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Solara Active Pharma Sciences Limited (NSE:SOLARAPP) Soars 38% But It's A Story Of Risk Vs Reward
Sep 19
We Think Solara Active Pharma Sciences (NSE:SOLARAPP) Has A Fair Chunk Of Debt
Aug 24Investors Still Aren't Entirely Convinced By Solara Active Pharma Sciences Limited's (NSE:SOLARAPP) Revenues Despite 55% Price Jump
Jul 28Gelir ve Gider Dağılımı
Solara Active Pharma Sciences nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Sep 24 | 12,218 | -5,361 | 2,324 | 0 |
| 30 Jun 24 | 13,001 | -5,613 | 2,378 | 0 |
| 31 Mar 24 | 12,889 | -5,674 | 2,500 | 0 |
| 31 Dec 23 | 14,069 | -3,077 | 2,503 | 0 |
| 30 Sep 23 | 15,529 | -325 | 2,461 | 0 |
| 30 Jun 23 | 14,661 | -253 | 2,359 | 0 |
| 31 Mar 23 | 14,438 | -222 | 2,308 | 0 |
| 31 Dec 22 | 14,240 | -241 | 2,150 | 0 |
| 30 Sep 22 | 11,296 | -1,644 | 2,221 | 0 |
| 30 Jun 22 | 11,928 | -1,247 | 2,319 | 0 |
| 31 Mar 22 | 12,683 | -581 | 2,392 | 0 |
| 31 Dec 21 | 13,517 | -34 | 2,529 | 0 |
| 30 Sep 21 | 16,781 | 2,023 | 2,472 | 0 |
| 30 Jun 21 | 16,740 | 2,293 | 2,393 | 0 |
| 31 Mar 21 | 16,169 | 2,214 | 2,327 | 0 |
| 31 Dec 20 | 14,694 | 1,826 | 2,297 | 0 |
| 30 Sep 20 | 13,864 | 1,581 | 2,212 | 0 |
| 30 Jun 20 | 13,400 | 1,304 | 2,139 | 0 |
| 31 Mar 20 | 13,218 | 1,146 | 2,080 | 0 |
| 31 Dec 19 | 14,103 | 1,231 | 2,059 | 0 |
| 30 Sep 19 | 14,228 | 1,039 | 2,032 | 0 |
| 30 Jun 19 | 14,140 | 845 | 1,986 | 0 |
| 31 Mar 19 | 13,867 | 614 | 1,927 | 0 |
| 31 Mar 18 | 5,210 | 60 | 710 | 0 |
Kaliteli Kazançlar: SOLARAPP is currently unprofitable.
Büyüyen Kar Marjı: SOLARAPP is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: SOLARAPP is unprofitable, and losses have increased over the past 5 years at a rate of 72.5% per year.
Büyüme Hızlandırma: Unable to compare SOLARAPP's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: SOLARAPP is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (19.1%).
Özkaynak Getirisi
Yüksek ROE: SOLARAPP has a negative Return on Equity (-49.26%), as it is currently unprofitable.